Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi Research Article
Perineural versus Intravenous Dexamethasone for Prolongation of Multiple Nerve Blocks for Pain Relief after Total Knee Arthroplasty
Anatoli Stav1,2*, Leonid Reytman2,3, Michael-Yohay Stav4, Aksana Machluf5, Roger Sevi2,6 and Mohammed Tallas7
1Postanesthesia Care Unit, Hillel Yaffe Medical Center, Hadera, Israel
2Department of Medicine, Technion-Israel Institute of Technology, Haifa, Israel
3Department of Anesthesiology, Hillel Yaffe Medical Center, Hadera, Israel
4Assaf Harofeh Medical Center, Zerifin, Israel
5Hillel Yaffe Medical Center, Hadera, Israel
6Department of Orthopedics A, Hillel Yaffe Medical Center, Hadera, Israel
7Department of Orthopedics B, Hillel Yaffe Medical Center, Hadera, Israel
- *Corresponding Author:
- Anatoli Stav
Postanesthesia Care Unit, Hillel Yaffe Medical Center
Hadera, 38100, Israel
Tel: +972-522696680
Fax: +972-46334539
E-mail: anatoli99@bezeqint.net
Received date: June 03, 2017; Accepted date: June 20, 2017; Published date: June 26, 2017
Citation: Stav A, Reytman L, Stav MY, Machluf A, Sevi R, et al. (2017) Perineural versus Intravenous Dexamethasone for Prolongation of Multiple Nerve Blocks for Pain Relief after Total Knee Arthroplasty. J Pain Relief 6:293. doi:10.4172/2167-0846.1000293
Copyright: © 2017 Stav A, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Abstract
Background: Multiple nerve blocks (MNB) provide excellent time-limited perioperative analgesia following total knee arthroplasty. Both perineural and systemic use of dexamethasone (DXM) as an adjuvant to local anesthetic prolong the duration of single-shot MNB. We hypothesized that preoperative perineural injection of DXM prolongs analgesia after MNB more than the same dose of intravenous (IV) DXM injection due to direct action on the nerves and not only by a systemic action mechanism.
Methods: This is a prospective, randomized, controlled and observer-blinded study. One hundred and nine patients were randomly assigned to one of three groups: Group (Gr) 1-perineural DXM+MNB, Gr 2-systemic IV DXM +MNB, Gr 3-control group, MNB without DXM. Postoperative variables including intensity of pain at rest and during motion, grade of sensory and motor block, opioid consumption, comfort time (the first analgesic request) were the primary end-points of investigation.
Results: Ninety patients completed the study protocol. Very low parameters of intensity of pain at rest and during motion, high grade of sensory and motor block were observed up to 12 hours after MNB performance in all three groups. Patients who received MNB with DXM perineurally or systemically, experienced superior pain relief and had reduced opioid consumption 24 hours post-block compared to the control group without differences between the two "dexamethasone" groups. There were no differences between groups at 36 and 48 hours post-block. Patients in the control group suffered from pain at rest and started treatment by any analgesics significantly earlier than patients from the two “dexamethasone” groups. No difference of comfort time was observed between Gr 1 and Gr 2. In the period between 24 and up to 36 hours the block’s effect (i.e. the effect of local anesthetic with adjuvant dexamethasone) gradually weakened and somewhere at 48 hours post-block, it passed almost completely.
Conclusions: Intravenous 8 mg dexamethasone is equivalent to perineural dexamethasone in prolonging the pain relief duration of an ultrasound guided single-shot multiple nerve block with bupivacaine and adrenaline following total knee arthroplasty.
